estreptococcal 感染症で崩壊する.

Same author

Trends in non-coeliac gluten/wheat sensitivity: a self-managed problem?

Scandinavian journal of gastroenterology·2025

Same author

Can Passive Cough Monitoring Predict COPD Exacerbations?

COPD·2025

Same author

Author Correction: Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites.

NPJ primary care respiratory medicine·2024

Same author

Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites.

NPJ primary care respiratory medicine·2024

Same author

Diet and irritable bowel syndrome: an update from a UK consensus meeting.

BMC medicine·2022

Same author

NCGS like IBS 'type' symptoms is a diagnosis of exclusion.

Nutrition journal·2021

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

estreptococcal 感染症で崩壊する.

関連する概念動画

Trends in non-coeliac gluten/wheat sensitivity: a self-managed problem?

Can Passive Cough Monitoring Predict COPD Exacerbations?

Author Correction: Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites.

Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites.

Diet and irritable bowel syndrome: an update from a UK consensus meeting.

NCGS like IBS 'type' symptoms is a diagnosis of exclusion.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

estreptococcal 感染症で崩壊する.

関連する概念動画

関連記事

Trends in non-coeliac gluten/wheat sensitivity: a self-managed problem?

Can Passive Cough Monitoring Predict COPD Exacerbations?

Author Correction: Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites.

Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites.

Diet and irritable bowel syndrome: an update from a UK consensus meeting.

NCGS like IBS 'type' symptoms is a diagnosis of exclusion.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.